What’s New

***PRESS RELEASE*** New Paper “The ICER Myth” Explores Drawbacks of ICER’s Evidence Reports and Their Impact on Patients

ICER has come under scrutiny for its methodology and calculations that impact patient access to approved therapies. WASHINGTON – The nonprofit Institute for Patient Access (IfPA)

Read More

Mapping Report Reveals Access Disparities among European Patients

How accessible is your health care?  It all depends upon where you live, as a new report from the European Federation of Crohn’s & Ulcerative

Read More

The FDA Invitation that Patient Advocates are Awaiting

Open dialogue is an important part of the drug approval process. Physicians, patients and advocates want transparent discussion about new therapies — their benefits, their

Read More

What Medicare’s Opioid Policy Left Out

More than 1,000 people per day receive treatment in emergency rooms across the country for misusing prescription opioids. And approximately 115 Americans die daily from

Read More

***PRESS RELEASE*** Alabama Health Plans Reject More Than a Third of Claims for High Cholesterol Treatment

Health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations WASHINGTON – The non-profit Institute for Patient Access released a new Health Plan Coverage

Read More

***PRESS RELEASE*** New York Health Plans Reject Nearly a Third of Claims for High Cholesterol Treatment

Health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations WASHINGTON – The non-profit Institute for Patient Access released a new Health Plan Coverage

Read More

***PRESS RELEASE*** Some Mississippi Health Plans Reject Over 90 Percent of Claims for High Cholesterol Treatment

Health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The non-profit Institute for Patient Access released a new Health Plan Coverage

Read More

***PRESS RELEASE*** Texas Health Plans Reject Over 7,000 Claims for High Cholesterol Treatment

Health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations WASHINGTON – The non-profit Institute for Patient Access released a new Health

Read More

***PRESS RELEASE*** California Health Plans Reject Over 6,000 Claims for High Cholesterol Treatment

Health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations WASHINGTON – The non-profit Institute for Patient Access released a new Health

Read More

***PRESS RELEASE*** Georgia Health Plans Reject One-Third of Claims for High Cholesterol Treatment

Georgia Health Plans Reject One-Third of Claims for High Cholesterol Treatment WASHINGTON – The non-profit Institute for Patient Access released a new Health Plan Coverage

Read More
Back to Top